Table 1

Study sites and number of cases of extranodal NK/T-cell lymphoma by site and region

RegionTotal cases, nNasal NK/T-cell lymphoma, n (%)Extranasal NK/T-cell lymphoma, n (%)Aggressive NK-cell leukemia, n (%)Unclassifiable NK-cell lymphoma, n (%)All NK/T-cell cases, n (%)
Bangkok, Thailand 41 14 (34) 7 (17)   21 (51) 
Hong Kong, China 58 12 (21) 5 (9)  3 (5) 20 (34) 
Singapore 34 9 (27) 8 (24)  2 (6) 19 (56) 
Seoul, Korea 27 5 (19) 6 (22)   11 (41) 
Tokyo, Japan 32 4 (13)    4 (13) 
Nagoya, Japan 54 9 (17) 1 (2)   10 (19) 
Okayama, Japan 36 7 (20)    7 (19) 
Fukuoka, Japan 182 11 (6)  1 (0.5)  12 (7) 
Asian total 464 71 (15) 27 (6) 1 (0.2) 5 (1) 104 (22) 
Europe and North America 689 21 (3) 8 (1) 1 (0.1) 2 (0.3) 32 (5) 
RegionTotal cases, nNasal NK/T-cell lymphoma, n (%)Extranasal NK/T-cell lymphoma, n (%)Aggressive NK-cell leukemia, n (%)Unclassifiable NK-cell lymphoma, n (%)All NK/T-cell cases, n (%)
Bangkok, Thailand 41 14 (34) 7 (17)   21 (51) 
Hong Kong, China 58 12 (21) 5 (9)  3 (5) 20 (34) 
Singapore 34 9 (27) 8 (24)  2 (6) 19 (56) 
Seoul, Korea 27 5 (19) 6 (22)   11 (41) 
Tokyo, Japan 32 4 (13)    4 (13) 
Nagoya, Japan 54 9 (17) 1 (2)   10 (19) 
Okayama, Japan 36 7 (20)    7 (19) 
Fukuoka, Japan 182 11 (6)  1 (0.5)  12 (7) 
Asian total 464 71 (15) 27 (6) 1 (0.2) 5 (1) 104 (22) 
Europe and North America 689 21 (3) 8 (1) 1 (0.1) 2 (0.3) 32 (5) 

Among 8 Asian centers, HTLV-1 was endemic only in Fukuoka, Japan.

Close Modal

or Create an Account

Close Modal
Close Modal